| 产品名称： | Influenza B virus |
|---|---|
| 商品货号： | TS213638 |
| Classification： | Orthomyxoviridae, Influenzavirus B |
| Agent： | Influenza B virus |
| Strain： | B/R22 Barbara |
| Applications： | Influenza Research |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Isolation： | Recombinant of B/Hong Kong/5/72 (VR 791) and B/Brigit (VR 786) |
| Product Format： | frozen |
| Storage Conditions： | -70°C or colder |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Comments： | Strain influenza B/Hong Kong/5/72 antigenicity. Completely resistant to serum inhibitor, positive allantoic on shell marker, negative hemagglutinin thermosensitivity at 60C; stable hemagglutination of sheep RBCs at 30C. |
| Effect on Host： | Yes, in vitro effects: Hemagglutination activity hemagglutinates chicken RBC |
| Recommended Host： | chicken embryo Recommended Host: SPF CE (10 to 11 day, intra allantoic) |
| Growth Conditions： | Temperature: 37.0°C Duration: 1-4 days |
| Name of Depositor： | R.I.T. - Recherche et Industrie Therapeutiques |
| U.S. Patent： | |
| U.S. Patent Number： | |
| Source： | Recombinant of B/Hong Kong/5/72 (VR 791) and B/Brigit (VR 786) |
| References： | Peetermans J, et al. Live influenza type B virus vaccines and preparation thereof. US Patent 3,962,423 dated Jun 8 1976 |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Influenza B virus |
|---|---|
| 商品货号： | TS213638 |
| Classification： | Orthomyxoviridae, Influenzavirus B |
| Agent： | Influenza B virus |
| Strain： | B/R22 Barbara |
| Applications： | Influenza Research |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Isolation： | Recombinant of B/Hong Kong/5/72 (VR 791) and B/Brigit (VR 786) |
| Product Format： | frozen |
| Storage Conditions： | -70°C or colder |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Comments： | Strain influenza B/Hong Kong/5/72 antigenicity. Completely resistant to serum inhibitor, positive allantoic on shell marker, negative hemagglutinin thermosensitivity at 60C; stable hemagglutination of sheep RBCs at 30C. |
| Effect on Host： | Yes, in vitro effects: Hemagglutination activity hemagglutinates chicken RBC |
| Recommended Host： | chicken embryo Recommended Host: SPF CE (10 to 11 day, intra allantoic) |
| Growth Conditions： | Temperature: 37.0°C Duration: 1-4 days |
| Name of Depositor： | R.I.T. - Recherche et Industrie Therapeutiques |
| U.S. Patent： | |
| U.S. Patent Number： | |
| Source： | Recombinant of B/Hong Kong/5/72 (VR 791) and B/Brigit (VR 786) |
| References： | Peetermans J, et al. Live influenza type B virus vaccines and preparation thereof. US Patent 3,962,423 dated Jun 8 1976 |
